Agios Pharmaceuticals, Inc. ( AGIO) - Key Metrics
AGIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.93 | -$1.09 | -$0.99 | -$1.01 |
| 2026Q2 | $0.75 | -$1.69 | -$0.96 | -$0.98 |
| 2026Q1 | $0.35 | -$1.69 | -$2.02 | -$2.04 |
| 2025Q4 | $0.34 | -$1.85 | -$1.65 | -$1.67 |
| 2025Q3 | $0.22 | -$1.78 | -$1.52 | -$1.54 |
AGIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -7.63 |
| 2026Q2 | 0% | -5.49 |
| 2026Q1 | 0% | -5.00 |
| 2025Q4 | 0% | -3.68 |
| 2025Q3 | 0% | -5.64 |
AGIO
Price: $31.63
52 week price:
Earnings Per Share: -6.52 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 44002
Ebitda: -88.5 millionMarket Capitalization: 2.0 billion